We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lipitor Ruling Could Affect Other Patent Cases, Experts Say
Lipitor Ruling Could Affect Other Patent Cases, Experts Say
October 18, 2005
If a U.S. court strikes down Pfizer’s formulation patent for Lipitor, like a British court recently did, it could set a bad precedent for other drugs such as Lexapro and Plavix that are facing U.S. challenges to the same kind of patents, legal experts say.